3.22.1 html 224 405 1 false 91 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.beyondspringpharma.com/20211231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.beyondspringpharma.com/20211231/role/statement-consolidated-balance-sheets- Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.beyondspringpharma.com/20211231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://www.beyondspringpharma.com/20211231/role/statement-consolidated-statements-of-comprehensive-loss- Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Shareholders' Equity (Deficit) Sheet http://www.beyondspringpharma.com/20211231/role/statement-consolidated-statements-of-shareholders-equity-deficit Consolidated Statements of Shareholders' Equity (Deficit) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.beyondspringpharma.com/20211231/role/statement-consolidated-statements-of-cash-flows- Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Nature of the Business Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-1-nature-of-the-business Note 1 - Nature of the Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Short-term Investments Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-3-shortterm-investments Note 3 - Short-term Investments Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Collaboration Revenue Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-4-collaboration-revenue Note 4 - Collaboration Revenue Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Property and Equipment, Net Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-5-property-and-equipment-net Note 5 - Property and Equipment, Net Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Long-term Loans Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-6-longterm-loans Note 6 - Long-term Loans Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Related Party Transactions Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-7-related-party-transactions Note 7 - Related Party Transactions Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Income Taxes Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes Note 8 - Income Taxes Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Net Loss Per Share Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-9-net-loss-per-share Note 9 - Net Loss Per Share Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Share-based Compensation Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation Note 10 - Share-based Compensation Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Employee Defined Contribution Plan Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-11-employee-defined-contribution-plan Note 11 - Employee Defined Contribution Plan Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Restricted Net Assets Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-12-restricted-net-assets Note 12 - Restricted Net Assets Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Lease Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-13-lease- Note 13 - Lease Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Supplemental Balance Sheet Information Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-14-supplemental-balance-sheet-information Note 14 - Supplemental Balance Sheet Information Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Contingently Redeemable Noncontrolling Interests Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-15-contingently-redeemable-noncontrolling-interests- Note 15 - Contingently Redeemable Noncontrolling Interests Notes 21 false false R22.htm 021 - Disclosure - Note 16 - Forward Contract Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-16-forward-contract Note 16 - Forward Contract Notes 22 false false R23.htm 022 - Disclosure - Note 17 - Accumulated Other Comprehensive Income (Loss) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-17-accumulated-other-comprehensive-income-loss Note 17 - Accumulated Other Comprehensive Income (Loss) Notes 23 false false R24.htm 023 - Disclosure - Note 18 - Commitments and Contingencies Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-18-commitments-and-contingencies Note 18 - Commitments and Contingencies Notes 24 false false R25.htm 024 - Disclosure - Note 19 - Subsequent Event Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-19-subsequent-event Note 19 - Subsequent Event Notes 25 false false R26.htm 025 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.beyondspringpharma.com/20211231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies 26 false false R27.htm 026 - Disclosure - Note 1 - Nature of the Business (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-1-nature-of-the-business-tables Note 1 - Nature of the Business (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-1-nature-of-the-business 27 false false R28.htm 027 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies 28 false false R29.htm 028 - Disclosure - Note 3 - Short-term Investments (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-3-shortterm-investments-tables Note 3 - Short-term Investments (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-3-shortterm-investments 29 false false R30.htm 029 - Disclosure - Note 4 - Collaboration Revenue (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-4-collaboration-revenue-tables Note 4 - Collaboration Revenue (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-4-collaboration-revenue 30 false false R31.htm 030 - Disclosure - Note 5 - Property and Equipment, Net (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-5-property-and-equipment-net-tables Note 5 - Property and Equipment, Net (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-5-property-and-equipment-net 31 false false R32.htm 031 - Disclosure - Note 8 - Income Taxes (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes-tables Note 8 - Income Taxes (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes 32 false false R33.htm 032 - Disclosure - Note 9 - Net Loss Per Share (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-9-net-loss-per-share-tables Note 9 - Net Loss Per Share (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-9-net-loss-per-share 33 false false R34.htm 033 - Disclosure - Note 10 - Share-based Compensation (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation-tables Note 10 - Share-based Compensation (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation 34 false false R35.htm 034 - Disclosure - Note 13 - Lease (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-13-lease-tables Note 13 - Lease (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-13-lease- 35 false false R36.htm 035 - Disclosure - Note 14 - Supplemental Balance Sheet Information (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-14-supplemental-balance-sheet-information-tables Note 14 - Supplemental Balance Sheet Information (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-14-supplemental-balance-sheet-information 36 false false R37.htm 036 - Disclosure - Note 15 - Contingently Redeemable Noncontrolling Interests (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-15-contingently-redeemable-noncontrolling-interests-tables Note 15 - Contingently Redeemable Noncontrolling Interests (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-15-contingently-redeemable-noncontrolling-interests- 37 false false R38.htm 037 - Disclosure - Note 17 - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-17-accumulated-other-comprehensive-income-loss-tables Note 17 - Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-17-accumulated-other-comprehensive-income-loss 38 false false R39.htm 038 - Disclosure - Note 18 - Commitments and Contingencies (Tables) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-18-commitments-and-contingencies-tables Note 18 - Commitments and Contingencies (Tables) Tables http://www.beyondspringpharma.com/20211231/role/statement-note-18-commitments-and-contingencies 39 false false R40.htm 039 - Disclosure - Note 1 - Nature of the Business (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-1-nature-of-the-business-details-textual Note 1 - Nature of the Business (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-1-nature-of-the-business-tables 40 false false R41.htm 040 - Disclosure - Note 1 - Nature of the Business - Schedule of Subsidiaries (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-1-nature-of-the-business-schedule-of-subsidiaries-details Note 1 - Nature of the Business - Schedule of Subsidiaries (Details) Details 41 false false R42.htm 041 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies-tables 42 false false R43.htm 042 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Useful Life of Property, Plant, and Equipment (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies-useful-life-of-property-plant-and-equipment-details Note 2 - Summary of Significant Accounting Policies - Useful Life of Property, Plant, and Equipment (Details) Details 43 false false R44.htm 043 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Schedule of Fair Value of Assets and Liabilities Measured On Recurring Basis (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies-schedule-of-fair-value-of-assets-and-liabilities-measured-on-recurring-basis-details Note 2 - Summary of Significant Accounting Policies - Schedule of Fair Value of Assets and Liabilities Measured On Recurring Basis (Details) Details 44 false false R45.htm 044 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Assumptions Used to Estimate the Fair Value of the Forward Liability (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies-assumptions-used-to-estimate-the-fair-value-of-the-forward-liability-details Note 2 - Summary of Significant Accounting Policies - Assumptions Used to Estimate the Fair Value of the Forward Liability (Details) Details 45 false false R46.htm 045 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Reconciliation of Changes in Fair Value (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies-reconciliation-of-changes-in-fair-value-details Note 2 - Summary of Significant Accounting Policies - Reconciliation of Changes in Fair Value (Details) Details 46 false false R47.htm 046 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Property and Equipment by Geographical Location (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-2-summary-of-significant-accounting-policies-property-and-equipment-by-geographical-location-details Note 2 - Summary of Significant Accounting Policies - Property and Equipment by Geographical Location (Details) Details 47 false false R48.htm 047 - Disclosure - Note 3 - Short-term Investments - Short-term Investments (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-3-shortterm-investments-shortterm-investments-details Note 3 - Short-term Investments - Short-term Investments (Details) Details 48 false false R49.htm 048 - Disclosure - Note 4 - Collaboration Revenue (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-4-collaboration-revenue-details-textual Note 4 - Collaboration Revenue (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-4-collaboration-revenue-tables 49 false false R50.htm 049 - Disclosure - Note 4 - Collaboration Revenue - Schedule of Collaboration Revenue (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-4-collaboration-revenue-schedule-of-collaboration-revenue-details Note 4 - Collaboration Revenue - Schedule of Collaboration Revenue (Details) Details 50 false false R51.htm 050 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-5-property-and-equipment-net-details-textual Note 5 - Property and Equipment, Net (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-5-property-and-equipment-net-tables 51 false false R52.htm 051 - Disclosure - Note 5 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-5-property-and-equipment-net-schedule-of-property-and-equipment-details Note 5 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Details 52 false false R53.htm 052 - Disclosure - Note 6 - Long-term Loans (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-6-longterm-loans-details-textual Note 6 - Long-term Loans (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-6-longterm-loans 53 false false R54.htm 053 - Disclosure - Note 7 - Related Party Transactions (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-7-related-party-transactions-details-textual Note 7 - Related Party Transactions (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-7-related-party-transactions 54 false false R55.htm 054 - Disclosure - Note 8 - Income Taxes (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes-details-textual Note 8 - Income Taxes (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes-tables 55 false false R56.htm 055 - Disclosure - Note 8 - Income Taxes - Components of Losses Before Income Taxes (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement--note-8-income-taxes-components-of-losses-before-income-taxes-details Note 8 - Income Taxes - Components of Losses Before Income Taxes (Details) Details 56 false false R57.htm 056 - Disclosure - Note 8 - Income Taxes - Provision for Income Expense (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes-provision-for-income-expense-details Note 8 - Income Taxes - Provision for Income Expense (Details) Details 57 false false R58.htm 057 - Disclosure - Note 8 - Income Taxes - Reconciliation of Income Tax Expenses (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes-reconciliation-of-income-tax-expenses-details Note 8 - Income Taxes - Reconciliation of Income Tax Expenses (Details) Details 58 false false R59.htm 058 - Disclosure - Note 8 - Income Taxes - Deferred Tax Assets (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes-deferred-tax-assets-details Note 8 - Income Taxes - Deferred Tax Assets (Details) Details 59 false false R60.htm 059 - Disclosure - Note 8 - Income Taxes - Unrecognized Tax Benefits (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-8-income-taxes-unrecognized-tax-benefits-details Note 8 - Income Taxes - Unrecognized Tax Benefits (Details) Details 60 false false R61.htm 060 - Disclosure - Note 9 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-9-net-loss-per-share-basic-and-diluted-net-loss-per-share-details Note 9 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Details 61 false false R62.htm 061 - Disclosure - Note 10 - Share-based Compensation (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation-details-textual Note 10 - Share-based Compensation (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation-tables 62 false false R63.htm 062 - Disclosure - Note 10 - Share-based Compensation - Restricted Share Activities (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation-restricted-share-activities-details Note 10 - Share-based Compensation - Restricted Share Activities (Details) Details 63 false false R64.htm 063 - Disclosure - Note 10 - Share-based Compensation - Options Activities (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation-options-activities-details Note 10 - Share-based Compensation - Options Activities (Details) Details 64 false false R65.htm 064 - Disclosure - Note 10 - Share-based Compensation - Fair Value Assumptions (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation-fair-value-assumptions-details Note 10 - Share-based Compensation - Fair Value Assumptions (Details) Details 65 false false R66.htm 065 - Disclosure - Note 10 - Share-based Compensation - Share-based Compensation Expense (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-10-sharebased-compensation-sharebased-compensation-expense-details Note 10 - Share-based Compensation - Share-based Compensation Expense (Details) Details 66 false false R67.htm 066 - Disclosure - Note 11 - Employee Defined Contribution Plan (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-11-employee-defined-contribution-plan-details-textual Note 11 - Employee Defined Contribution Plan (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-11-employee-defined-contribution-plan 67 false false R68.htm 067 - Disclosure - Note 12 - Restricted Net Assets (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-12-restricted-net-assets-details-textual Note 12 - Restricted Net Assets (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-12-restricted-net-assets 68 false false R69.htm 068 - Disclosure - Note 13 - Lease (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-13-lease-details-textual Note 13 - Lease (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-13-lease-tables 69 false false R70.htm 069 - Disclosure - Note 13 - Lease - Maturities of Lease Liabilities (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-13-lease-maturities-of-lease-liabilities-details Note 13 - Lease - Maturities of Lease Liabilities (Details) Details 70 false false R71.htm 070 - Disclosure - Note 13 - Lease - Operating Lease Disclosure (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-13-lease-operating-lease-disclosure-details Note 13 - Lease - Operating Lease Disclosure (Details) Details 71 false false R72.htm 071 - Disclosure - Note 14 - Supplemental Balance Sheet Information - Other Noncurrent Assets (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-14-supplemental-balance-sheet-information-other-noncurrent-assets-details Note 14 - Supplemental Balance Sheet Information - Other Noncurrent Assets (Details) Details 72 false false R73.htm 072 - Disclosure - Note 14 - Supplemental Balance Sheet Information - Other Current Liabilities (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-14-supplemental-balance-sheet-information-other-current-liabilities-details Note 14 - Supplemental Balance Sheet Information - Other Current Liabilities (Details) Details 73 false false R74.htm 073 - Disclosure - Note 15 - Contingently Redeemable Noncontrolling Interests (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-15-contingently-redeemable-noncontrolling-interests-details-textual Note 15 - Contingently Redeemable Noncontrolling Interests (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-15-contingently-redeemable-noncontrolling-interests-tables 74 false false R75.htm 074 - Disclosure - Note 15 - Contingently Redeemable Noncontrolling Interests - Redeemable Noncontrolling Interests, Net of Issuance Costs (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-15-contingently-redeemable-noncontrolling-interests-redeemable-noncontrolling-interests-net-of-issuance-costs-details Note 15 - Contingently Redeemable Noncontrolling Interests - Redeemable Noncontrolling Interests, Net of Issuance Costs (Details) Details 75 false false R76.htm 075 - Disclosure - Note 16 - Forward Contract (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-16-forward-contract-details-textual Note 16 - Forward Contract (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-16-forward-contract 76 false false R77.htm 076 - Disclosure - Note 17 - Accumulated Other Comprehensive Income (Loss) - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-17-accumulated-other-comprehensive-income-loss-accumulated-other-comprehensive-income-loss-details Note 17 - Accumulated Other Comprehensive Income (Loss) - Accumulated Other Comprehensive Income (Loss) (Details) Details http://www.beyondspringpharma.com/20211231/role/statement-note-17-accumulated-other-comprehensive-income-loss-tables 77 false false R78.htm 077 - Disclosure - Note 18 - Commitments and Contingencies (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-18-commitments-and-contingencies-details-textual Note 18 - Commitments and Contingencies (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-18-commitments-and-contingencies-tables 78 false false R79.htm 078 - Disclosure - Note 18 - Commitments and Contingencies (Details) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-18-commitments-and-contingencies-details Note 18 - Commitments and Contingencies (Details) Details http://www.beyondspringpharma.com/20211231/role/statement-note-18-commitments-and-contingencies-tables 79 false false R80.htm 079 - Disclosure - Note 19 - Subsequent Event (Details Textual) Sheet http://www.beyondspringpharma.com/20211231/role/statement-note-19-subsequent-event-details-textual Note 19 - Subsequent Event (Details Textual) Details http://www.beyondspringpharma.com/20211231/role/statement-note-19-subsequent-event 80 false false All Reports Book All Reports bysi20211231_20f.htm bysi-20211231.xsd bysi-20211231_cal.xml bysi-20211231_def.xml bysi-20211231_lab.xml bysi-20211231_pre.xml ex_357805.htm ex_357806.htm ex_357807.htm ex_357808.htm ex_357809.htm ex_357810.htm ex_357811.htm ex_357812.htm ex_357813.htm ex_357814.htm ex_357815.htm ex_357816.htm ex_357817.htm ex_357818.htm ex_357823.htm ex_357828.htm ex_357829.htm ex_357830.htm ex_357839.htm ex_357846.htm ex_357854.htm p112.jpg p80.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true